PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mark McKeage Yongchuan Gu |
| Publication date | October 25, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |